Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $7.43 in the prior trading day, Evolus Inc (NASDAQ: EOLS) closed at $7.68, up 3.43%. In other words, the price has increased by $3.43 from its previous closing price. On the day, 1.34 million shares were traded. EOLS stock price reached its highest trading level at $7.91 during the session, while it also had its lowest trading level at $7.46.
Ratios:
Our goal is to gain a better understanding of EOLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.86 and its Current Ratio is at 2.27.
On April 17, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $21.
Barclays Upgraded its Equal Weight to Overweight on January 29, 2024, whereas the target price for the stock was revised from $10 to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when Stewart Brady bought 30,000 shares for $6.82 per share. The transaction valued at 204,486 led to the insider holds 88,629 shares of the business.
MOATAZEDI DAVID sold 111,323 shares of EOLS for $1,119,141 on Jun 13 ’25. The insider now owns 381,509 shares after completing the transaction at $10.05 per share. On Jun 16 ’25, another insider, MOATAZEDI DAVID, who serves as the insider of the company, sold 16,582 shares for $9.89 each. As a result, the insider received 164,054 and left with 364,927 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 496783872 and an Enterprise Value of 589952000. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.79. Its current Enterprise Value per Revenue stands at 2.123 whereas that against EBITDA is -16.771.
Stock Price History:
The Beta on a monthly basis for EOLS is 1.10, which has changed by -0.5142315 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $5.71. The 50-Day Moving Average of the stock is -11.23%, while the 200-Day Moving Average is calculated to be -31.42%.
Shares Statistics:
The stock has traded on average 1.41M shares per day over the past 3-months and 1383780 shares per day over the last 10 days, according to various share statistics. A total of 64.64M shares are outstanding, with a floating share count of 50.51M. Insiders hold about 15.40% of the company’s shares, while institutions hold 86.60% stake in the company. Shares short for EOLS as of 1753920000 were 13478555 with a Short Ratio of 9.54, compared to 1751241600 on 11995910. Therefore, it implies a Short% of Shares Outstanding of 13478555 and a Short% of Float of 21.3.
Earnings Estimates
The stock of Evolus Inc (EOLS) is currently in the spotlight, with 3.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $0.07, with high estimates of $0.13 and low estimates of $0.03.
Analysts are recommending an EPS of between -$0.45 and -$0.83 for the fiscal current year, implying an average EPS of -$0.55. EPS for the following year is $0.15, with 5.0 analysts recommending between $0.23 and $0.0.
Revenue Estimates
6 analysts predict $67.72M in revenue for the current quarter. It ranges from a high estimate of $71.01M to a low estimate of $65.3M. As of the current estimate, Evolus Inc’s year-ago sales were $61.09MFor the next quarter, 6 analysts are estimating revenue of $91.34M. There is a high estimate of $93.62M for the next quarter, whereas the lowest estimate is $89M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $302.54M, while the lowest revenue estimate was $294.6M, resulting in an average revenue estimate of $297.62M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $385.3M in the next fiscal year. The high estimate is $409M and the low estimate is $369.5M.
